MGTX · MeiraGTx Holdings plc

$13.81 -0.02 (-0.11%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.33B

96.04M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-04	Jefferies Global Healthcare Conference	Conference
2026-05-14	BofA Securities 2026 Global Healthcare Conference	Conference
2026-04-16	MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia	Event
2026-03-25	RBC Global Ophthalmology Conference	Conference
2025-12-03	8th Annual Evercore Healthcare Conference	Conference
2025-10-21	Chardan's 9th Annual Genetic Medicines Conference	Conference
2025-08-01	Chardan Virtual Ophthalmology Summit Series: Rare Ophthalmic Diseases	Event
2025-05-14	2025 Bank of America Health Care Conference	Conference
2025-04-29	Chardan's Data & Regulatory Catalysts – Navigating an Evolving Landscape	Event
2025-04-03	2025 RBC Capital Markets Ophthalmology Conference (Virtual)	Conference
2025-02-21	MeiraGTx Data Presentation for AAV-AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy	Presentation
2023-06-27	MeiraGTx Clinical Data Presentation from Phase 1 AQUAx Trial for Radiation-Induced Xerostomia	Presentation
2022-10-01	American Academy of Ophthalmology (AAO) 2022 Annual Meeting	Shareholder meeting
2022-09-16	MeiraGTx’s Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish Government	Event
2019-12-13	MeiraGTx Parkinson’s Disease R&D Day	Event

Source: https://meiragtx.com/investors-media/

Key facts CIK 1735438 CUSIP G59665102 13F (30d) 134 filings 132 filers Visit website Investor relations